Authors
Latest:
AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhDThe Elios procedure increased aqueous humor outflow in all investigated eyes, but further studies are needed to correlate these improvements with its clinical efficacy.
Latest:
MIGS helping to personalize glaucoma surgery optionsAlthough minimally invasive procedure gives hope, additional research is required.
Latest:
Shine on social media like ModaMD: Real World OphthalmologyAn overview of Jesse Berry’s advice for starting and growing a social media account
Latest:
Final Pearls on Managing Dry Eye Patients With ComorbiditiesOphthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.
Latest:
Boosting short-term dry eye management in patientsFast-acting efficacious options are key to treating acute inflammation
Latest:
IKA Keratoconus Symposium 2023: Strategies for early diagnosisAt the IKA Keratoconus Symposium, Justin Schweitzer, OD, FAAO, presented on establishing the keratoconus diagnosis alongside Kourtney Houser, MD.
Latest:
Keratoconus and perfect vision: Is it possible?Eye care providers must look beyond visual acuity in screening for disease.
Latest:
Children’s mental health and the impact of vision impairmentTwo studies conducted in collaboration with Orbis International explore how providing free glasses to children improves their ability to learn in school and that addressing visual impairment in children can alleviate depression and anxiety.
Latest:
IKA Keratoconus Symposium 2023: In-person white paper development, live patient Q&APresident and CEO of the International Keratoconus Academy Andrew Morgenstern, OD, FAAO, FNAP, shares some snippets about the live white paper development session and the patient Q&A happening at the inaugural IKA Keratoconus Symposium.
Latest:
Connecting the dots between the complement pathway and geographic atrophyCurrently enrolling a Phase 2 trial to evaluate the role of complement factor B protein in age-related macular degeneration (AMD)
Latest:
The tech savvy physician: How AI will transform your practiceInvestigators find technology aids instruction of medical students
Latest:
The impact of vision loss on aging: A glaucoma fellow’s perspectiveMoon Jeong Lee, MD, shares how volunteering in geriatric care shaped her career path.
Latest:
Femtosecond laser-assisted cataract surgery: One physician’s storyOphthalmologist outlines his journey with the procedure as a late adopter.
Latest:
BLOG: MicroPulse TLT for patients who struggle with dropsIn cases where patients struggle with applying or tolerating eye drops, especially after previous selective laser trabeculoplasty (SLT) treatment, MicroPulse transscleral laser therapy (TLT) offers a practical solution.
Latest:
Ophthalmology balances the promises and challenges of AISophisticated programs require an evolving mindset.
Latest:
AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPHAn AI model for target IOP prediction performs as well as glaucoma specialists, offering a promising tool to enhance glaucoma management, especially for nonspecialists.
Latest:
Blog: Cannabinol, a rare cannabinoid, shows unique therapeutic potential in glaucomaA recent study of cannabinol in in vitro and in vivo glaucoma models, demonstrated encouraging results that may address some of the previous challenges associated with cannabis use and may present a new potential therapeutic intervention in the treatment of glaucoma.
Latest:
The truth about invisible posterior vitreous structuresThe advanced swept-source OCT technology allows visualization of the variations in the normal changes and those associated with aging in the posterior vitreous.
Latest:
Pigskins and perception: How neuro-ophthalmology influences NFL refereesEvery football fan knows the scrutiny that NFL game officials are put under every game day, and now a group of ophthalmologists is trying to ensure they can perform at their best each weekend.
Latest:
Treating traumatic brain injury neuro-optometricallyPhysicians note the impact of prism lenses can be life-changing for patients.
Latest:
MCO-010 optogenetic gene therapy for severe vision loss in Stargardt diseaseThe treatment option can have a positive impact on quality of life for patients.
Latest:
Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.
Latest:
Study compares postoperative refractive accuracy of formula-modified keratometry values versus total keratometry values obtained by a swept-source OCT biometer with new-generation multivariable IOL calculation formulasOlder generation non-LVC formulas show marked improvement upon using TK values vs K, while multivariable non-LVC formulas did not consistently improve.
Latest:
Netarsudil provides IOP lowering in goniotomy treated eyesThe unique MOA may deliver a synergistic effect when prescribed post-surgically.
Latest:
Shifting paradigm in GA management means focusing attention on imagingOphthalmologists can use OCT to find the early signs of disease
Latest:
Advancement in TED treatment is a bright spotFDA approval of teprotumumab as therapeutic offers hope for patients.
Latest:
Protecting cataract patients and their surgeons' practicesMaximizing refractive surgery is key to ensuring prosperous future
Latest:
IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linkingJohn D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.
